Published in Transl Med UniSa on December 19, 2014
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J (2012) 18.18
Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2007) 17.85
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA (2005) 9.81
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Guidelines on myocardial revascularization. Eur Heart J (2010) 8.85
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol (2006) 8.27
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet (2004) 5.94
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation (2004) 5.44
Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA (2013) 3.88
Guidelines on myocardial revascularization. Eur J Cardiothorac Surg (2010) 3.47
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation (2006) 3.45
Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol (2005) 3.38
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet (2013) 3.17
Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol (2003) 3.13
Coronary artery stenting and non-cardiac surgery--a prospective outcome study. Br J Anaesth (2006) 3.08
Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol (2000) 3.01
Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med (2005) 2.98
Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res (2003) 2.56
Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation (2011) 2.40
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). J Am Coll Cardiol (2012) 2.28
Frequency and risk of noncardiac surgery after drug-eluting stent implantation. Catheter Cardiovasc Interv (2011) 2.18
Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol (2009) 2.16
Non-cardiac surgery and antiplatelet therapy following coronary artery stenting. Heart (2009) 2.15
Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol (2010) 2.00
Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv (2004) 1.76
Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv (2010) 1.75
Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth (2010) 1.71
Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol (2005) 1.56
Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study. Catheter Cardiovasc Interv (2011) 1.50
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA (2012) 1.43
Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation (2004) 1.42
Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol (2006) 1.30
Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis. Thromb Haemost (2010) 1.28
Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest (2006) 1.25
Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levels. Blood (2003) 1.23
Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year. J Am Coll Cardiol (2012) 1.16
New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems. Circ Cardiovasc Interv (2010) 1.14
Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation (2009) 1.02
Risks of noncardiac surgery after coronary stenting. Am J Cardiol (2005) 1.01
Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv (2010) 0.97
Late thrombosis of sirolimus-eluting stents following noncardiac surgery. Catheter Cardiovasc Interv (2005) 0.97
Pharmacology of emerging novel platelet inhibitors. Am Heart J (2008) 0.96
Prognostic value of the modified american college of Cardiology/American heart association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement. Circulation (1999) 0.95
Direct stenting of de novo coronary stenoses with tacrolimus-eluting versus carbon-coated carbostents. The randomized JUPITER II trial. EuroIntervention (2006) 0.93
Poor response to clopidogrel: current and future options for its management. J Thromb Thrombolysis (2010) 0.93
Synergy of passive coating and targeted drug delivery: the tacrolimus-eluting Janus CarboStent. J Interv Cardiol (2003) 0.91
Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting. Thromb Haemost (2009) 0.91
The incidence and timing of noncardiac surgery after cardiac stent implantation. J Am Coll Surg (2012) 0.89
Noncardiac surgery and bleeding after percutaneous coronary intervention. Circ Cardiovasc Interv (2009) 0.89
The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: a prospective observational study. Anesth Analg (2010) 0.88
Risk of noncardiac surgery after coronary drug-eluting stent implantation. Am J Cardiol (2006) 0.88
Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery. Circulation (2013) 0.88
Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery. J Thorac Cardiovasc Surg (2005) 0.84
Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial. Stroke (1993) 0.84
Abciximab (c7E3 Fab). A review of its pharmacology and therapeutic potential in ischaemic heart disease. Drugs (1994) 0.82
Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation: results from the Evaluation of Drug-Eluting Stents and Ischemic Events Registry. Am Heart J (2011) 0.81
[Use of eptifibatide in patients with acute stent thrombosis, requiring urgent surgical revascularisation - report of 2 cases]. Kardiol Pol (2009) 0.81
A new approach to percutaneous coronary revascularization in patients requiring undeferrable non-cardiac surgery. Int J Cardiol (2009) 0.81
Impact of surgery on local and systemic responses of cytokines and adhesion molecules. Hepatogastroenterology (2009) 0.80
Plasma concentrations but not serum concentrations of brain-derived neurotrophic factor are related to pro-inflammatory cytokines in patients undergoing major abdominal surgery. Clin Biochem (2012) 0.79
Pharmacotherapeutic considerations for the use of prasugrel and ticagrelor to reduce stent thrombosis in patients with acute coronary syndrome. Angiology (2012) 0.78
Antiplatelet theRapy after Genous EPC-capturing coroNary stenT implantatiOn: the ARGENTO study: a prospective, multicenter registry. Int J Cardiol (2012) 0.78
Perioperative hemorrhage and combined clopidogrel and aspirin therapy. Anesthesiology (2004) 0.77
Haemorrhage associated with combined clopidogrel and aspirin therapy. Eur J Vasc Endovasc Surg (2001) 0.76
Limited usefulness of the modified Academic Research Consortium stent thrombosis definition for clinical trials. JACC Cardiovasc Interv (2011) 0.76
Properties of a new carbon film for biomedical applications. Int J Artif Organs (1986) 0.75
Contemporary trends in coronary intervention: a report from the Registry of the Society for Cardiac Angiography and Interventions. Catheter Cardiovasc Interv (2000) 0.75
Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography. Circulation (1996) 4.24
Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation (1995) 2.23
Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med (1991) 2.06
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J (2005) 1.83
Local effect of serotonin released during coronary angioplasty. N Engl J Med (1994) 1.81
Effects of myocardial revascularization on regional thallium-201 uptake and systolic function in regions with reverse redistribution on tomographic thallium-201 imaging at rest in patients with chronic coronary artery disease. J Nucl Cardiol (1998) 1.45
Interventional cardiology in Europe 1994. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1998) 1.44
Interventional cardiology in Europe 1995. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1999) 1.36
Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. Br J Pharmacol (2007) 1.22
Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease. Circulation (1996) 1.10
Severity of coronary artery disease in patients with diabetes mellitus. Angiographic study of 34 diabetic and 120 nondiabetic patients. Am Heart J (1980) 0.94
Hemodynamic response to exercise after propranolol in patients with mitral stenosis. Am J Cardiol (1979) 0.91
Detection of soluble BAG3 and anti-BAG3 antibodies in patients with chronic heart failure. Cell Death Dis (2013) 0.87
Interventional cardiology in Europe 1993. Working Group on Coronary Circulation of the European Society of Cardiology. Eur Heart J (1996) 0.87
Noninvasive evaluation of left ventricular diastolic function in hypertrophic cardiomyopathy. Am J Cardiol (1998) 0.87
Influence of left ventricular asynchrony on filling in coronary artery disease. Am J Cardiol (1988) 0.85
Hemodynamic and ventilatory effects of intravenous salbutamol in patients affected by cold. Respiration (1980) 0.85
Effects of induced asynchrony on left ventricular diastolic function in patients with coronary artery disease. J Am Coll Cardiol (1993) 0.83
Endovascular procedures in critical leg ischemia of elderly patients. Acta Biomed (2005) 0.83
Values and limitations of transstenotic pressure gradients measured during percutaneous coronary angioplasty. Herz (1985) 0.82
Role of alpha 2-adrenoceptors in normal and atherosclerotic human coronary circulation. Circulation (1992) 0.81
Effects of dual-chamber pacing in hypertrophic cardiomyopathy on left ventricular outflow tract obstruction and on diastolic function. Am J Cardiol (1996) 0.80
Direct coronary stenting: effect on coronary blood flow, immediate and late clinical results. Catheter Cardiovasc Interv (2001) 0.80
Coronary artery vasoconstriction after successful single angioplasty of the left anterior descending artery. Am Heart J (1994) 0.79
Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy. Am J Cardiol (1996) 0.79
Limb vasoconstriction after successful angioplasty of the left anterior descending coronary artery. Circulation (1995) 0.79
Effects of intravenous verapamil on left ventricular relaxation and filling in stable angina pectoris. Am J Cardiol (1990) 0.79
Prediction of improvement in global left ventricular function in patients with chronic coronary artery disease and impaired left ventricular function: rest thallium-201 SPET versus low-dose dobutamine echocardiography. Eur J Nucl Med (2000) 0.78
Percutaneous coronary intervention in a patient with acute non-ST-elevation myocardial infarction and haemophilia A: a 'genous' experience. Haemophilia (2011) 0.78
Regional cardioprotection by subselective intracoronary nifedipine is not due to enhanced collateral flow during coronary angioplasty. Int J Cardiol (1987) 0.78
Influence of reversible segmental left ventricular dysfunction on heart period variability in patients with one-vessel coronary artery disease. J Am Coll Cardiol (1994) 0.77
Impaired left ventricular filling dynamics during percutaneous transluminal angioplasty for coronary artery disease. Am J Cardiol (1987) 0.77
Assessment of left ventricular diastolic function: comparison of contrast ventriculography and equilibrium radionuclide angiography. J Nucl Med (1991) 0.77
Impact of bivalirudin and Genous stent in patients with acute myeloid leukemia undergoing emergency percutaneous coronary angioplasty for acute coronary syndrome [corrected]. Leukemia (2012) 0.77
Digoxin-induced vasoconstriction of normal and atherosclerotic epicardial coronary arteries. Am J Cardiol (1991) 0.77
Endovascular vs. open surgery of abdominal aortic aneurysm in high-risk patients: a single center experience. Thorac Cardiovasc Surg (2005) 0.76
Inotropic stimulation by dobutamine increases left ventricular regional function at the expense of metabolism in hibernating myocardium. Am Heart J (1996) 0.76
Letter to editor re: endovascular repair of para-anastomotic aortic aueurysms. Eur J Vasc Endovasc Surg (2006) 0.75
Rays Sting: The Acute Cellular Effects of Ionizing Radiation Exposure. Transl Med UniSa (2016) 0.75
"Pro-healing" coronary stent before undeferrable major non-cardiac surgery. Heart (2010) 0.75
Mechanisms underlying pulmonary hypertension by hypoxemia. Adv Exp Med Biol (1984) 0.75
[Haemodynamic response to exercise after propranolol in mitral stenosis (author's transl)]. G Ital Cardiol (1978) 0.75
Sequential dilatation of septal and left anterior descending artery: single guiding catheter and double guide wire technique. Cathet Cardiovasc Diagn (1987) 0.75
[Influence of changes in heart rate on systolic time intervals]. Boll Soc Ital Cardiol (1977) 0.75
Evaluation of left ventricular asynchrony by radionuclide angiography: comparison of phase and sector analysis. J Nucl Med (1994) 0.75
[Importance of coronarographic evaluation in valvular diseases for correct surgical indication (author's transl)]. G Ital Cardiol (1976) 0.75
[Clinical, hemodynamic and angiographic findings in patients with prior myocardial infarct. Comparison with 79 coronary disease patients without infarct]. Minerva Cardioangiol (1980) 0.75
Systolic and diastolic time intervals during spontaneous angina. Clin Cardiol (1984) 0.75
[Heart function in chronic pressure overload caused by aortic stenosis: the role of collagen tissue]. Cardiologia (1994) 0.75
[The effects of the selective intracoronary administration of nifedipine on left ventricular filling anomalies during coronary angioplasty]. Cardiologia (1993) 0.75
Endovascular stent grafts as a safe secondary option for para-anastomotic abdominal aortic aneurysm. Eur J Vasc Endovasc Surg (2006) 0.75
Early changes in wall motion and wall thickness during percutaneous transluminal coronary angioplasty in man. Can J Cardiol (1986) 0.75
Diagnostic accuracy of low-dose dobutamine echocardiography in predicting post-revascularisation recovery of function in patients with chronic coronary artery disease: relationship to thallium-201 uptake. Eur J Nucl Med (2001) 0.75
Assessment of left ventricular function using radionuclide angiography after dipyridamole infusion. Chest (1989) 0.75
Usefulness of late coronary thrombolysis (recombinant tissue-type plasminogen activator) in preserving left ventricular function in acute myocardial infarction. Am J Cardiol (1990) 0.75
Dual chamber pacing in hypertrophic cardiomyopathy: influence of atrioventricular delay on left ventricular outflow tract obstruction. Cardiology (1998) 0.75
Combined evaluation of rest-redistribution thallium-201 tomography and low-dose dobutamine echocardiography enhances the identification of viable myocardium in patients with chronic coronary artery disease. Eur J Nucl Med (1998) 0.75
[Comparison between human "capillary" pulmonary pressure and left atrial pressure]. Boll Soc Ital Cardiol (1976) 0.75
[Severe mitral insufficiency without left atrial hypertension]. Cardiologia (1984) 0.75
Coronary flow reserve evaluation: basics, techniques and clinical applications. Minerva Cardioangiol (2009) 0.75
[Stenosis of the common trunk of the left coronary artery. Personal experience with 17 patients]. G Ital Cardiol (1979) 0.75
[Effects of antihistaminics on pulmonary hypertension caused by chronic hypoxia in humans]. Bronchopneumologie (1977) 0.75
Anterior S-T changes during acute inferior myocardial infarction. Int J Cardiol (1984) 0.75
[Percutaneous brachial approach in left cardiac catheterization]. G Ital Cardiol (1988) 0.75
Cardiac effects of atrial natriuretic peptide in subjects with normal left ventricular function. Am J Cardiol (1989) 0.75
[Behavior of some metabolic parameters during post-ischemic and post-contraction vasodilation in normal subjects]. Boll Soc Ital Cardiol (1975) 0.75
[The effects of atrial natriuretic peptide on left ventricular function in subjects with heart failure]. Cardiologia (1991) 0.75
Indirect pathway of liver glycogen synthesis in humans is predominant and independent of beta-adrenergic mechanisms. Clin Physiol (1992) 0.75
[Transluminal coronary angioplasty performed by percutaneous brachial approach]. Cardiologia (1988) 0.75
Primary PCI for the treatment of ectatic infarct-related coronary artery. Minerva Cardioangiol (2014) 0.75
[Coronary vasoconstriction induced by digoxin in normal subjects and in patients with coronary atherosclerosis]. Cardiologia (1993) 0.75
[Effects of diagitalis on the behavior of systolic time intervals (STI) during atrial electrostimulation (AE) in subjects with ischemic cardiopathy]. Boll Soc Ital Cardiol (1977) 0.75
New perspectives for transcatheter aortic valve implantation: more than a "simple" alternative to surgery. Minerva Cardioangiol (2014) 0.75
Electromechanical events during spontaneous angina. Cardiology (1988) 0.75
[Effects of coronary angioplasty on heart rate variability explored in the domain of time and frequency in patients with one-vessel coronary disease]. G Ital Cardiol (1994) 0.75
Effects of oral salt load on arginine-vasopressin secretion in normal subjects. Ann Clin Lab Sci (1987) 0.75
[Myocardial infarction in a patient with multiple coronary aneurysms]. Cardiologia (1984) 0.75
Evaluation of myocardial perfusion and function by technetium-99m methoxy isobutyl isonitrile before and after percutaneous transluminal coronary angioplasty. Preliminary results. Clin Nucl Med (1993) 0.75
Clinical hemodynamic and angiographic findings in 94 patients with old myocardial infarction. Comparison with 79 patients with coronary artery disease and no myocardial infarction. Jpn Heart J (1981) 0.75
[Behavior of systolic time intervals (STI) during atrial electrostimulation (AE) in normal subjects and in patients with ischemic cardiopathy]. Boll Soc Ital Cardiol (1977) 0.75
Myocardial release of hypoxanthine and lactate during percutaneous transluminal coronary angioplasty. Am J Cardiol (1989) 0.75
Multicenter evaluation of the XT modular coronary stent: clinical and angiographic results. G Ital Cardiol (1999) 0.75
[Echocardiographic size of the left atrium and pulmonary "capillary" pressure in different cardiopathies]. G Ital Cardiol (1979) 0.75
[Effects of atrial natriuretic peptide on left ventricular function in man]. Cardiologia (1989) 0.75